On the positive inotropic action of alkylating bromoacetates of strophanthidin and strophanthidol-[19-H3].
D000085:Acetates / Q000378:metabolism; D000251:Adenosine Triphosphatases / Q000302:isolation & purification / Q000378:metabolism; D000478:Alkylation; D000818:Animals; D001966:Bromine / Q000378:metabolism; D002297:Cardanolides / Q000378:metabolism / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects*; D006325:Heart Atria / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009206:Myocardium / Q000201:enzymology; D010042:Ouabain / Q000008:administration & dosage; D010477:Perfusion; D011188:Potassium / Q000378:metabolism; D011817:Rabbits; D011955:Receptors, Drug / Q000187:drug effects; D012964:Sodium / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D000085:Acetates; D002297:Cardanolides; D011955:Receptors, Drug; D014316:Tritium; D010042:Ouabain; D012964:Sodium; D000251:Adenosine Triphosphatases; D011188:Potassium; D001966:Bromine